Results 301 to 310 of about 2,114,452 (380)

How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak. [PDF]

NPJ Vaccines
Nsanzimana S, Bigirimana N, Hatchett R, Bailey S, Butera N, Butera Y, Cramer JP, Finan A, Forkin CM, Hacker AM, Hassan S, Leamy V, Mutabazi V, Nyombayire J, Remera E, Rwagasore E, Tedeschi E, Warfield KL, Lurie N.   +18 more
europepmc   +1 more source

Machine Learning‐Enhanced Nanoparticle Design for Precision Cancer Drug Delivery

Advanced Science, EarlyView.
Machine Learning (ML) is revolutionizing cancer nanomedicine by optimizing nanoparticle (NP) design and drug delivery. This review summarizes ML applications across all stages of NP drug delivery, along with a discussion of ongoing challenges and future directions.
Qingquan Wang, Yujian Liu, Chenchen Li, Bin Xu, Shidang Xu, Bin Liu   +5 more
wiley   +1 more source

Effects of a Theory- and Evidence-Based, Motivational Interviewing-Oriented Artificial Intelligence Digital Assistant on Vaccine Attitudes: A Randomized Controlled Trial.

J Med Internet Res
Li Y, Li M, Yorke J, Bressington D, Chung J, Xie YJ, Yang L, He M, Sun TC, Leung AYM.   +9 more
europepmc   +1 more source

First Among Equals: The Case for High-quality Clinical Data in Influenza Vaccines. [PDF]

Clin Infect Dis
Manning JE, Beckers F, de Bruijn I, Sridhar S, Gurunathan S.   +4 more
europepmc   +1 more source

APPLICATION OF VACCINES IN PUBLIC HEALTH WORK

, 1920
GEORGE W. McCOY
openalex   +2 more sources

Cryogel‐Based Dendritic Cell Immunotherapy for Post‐Surgical Breast Cancer Treatment

Advanced Science, EarlyView.
A multifunctional GelMA cryogel enables dendritic cell immunotherapy that synergizes with doxorubicin and PD‐1 blockade, driving robust post‐surgical T‐cell immunity and suppressing TNBC recurrence. Abstract Triple‐negative breast cancer (TNBC) is an aggressive malignancy with high mortality and limited treatment options.
Lam‐Duc‐Huy Nguyen, Sheng‐Liang Cheng, Yu‐Ting Yen, Hsin‐Mei Lee, Te‐Haw Wu, Jane Wang, Shu‐Yi Lin, Yunching Chen   +7 more
wiley   +1 more source

Controlling Release Kinetics of an Adjuvant from a Depot Improves the Efficacy of Local Immunotherapy in Metastatic Cancer

Advanced Science, EarlyView.
We show that intratumoral release of an immunotherapy—CpG —can be tuned with molecular precision by complexing it to an elastin‐like polypeptide (ELP). Injecting ELP‐CpG and an excipient ELP into tumors drives thermally‐triggered phase separation into a micro‐scale “sponge” depot that releases CpG at rates depending on the ELP composition, which ...
Joshua J. Milligan, Rachel L. Strader, Arunangshu Chakrabarty, Max Ney, Parul Sirohi, Jonathan C. Su, Anastasia K. Varanko, Yulia Shmidov, Kalina Tsolova, Cassio Mendes Fontes, Anna Finkelstein, Rohinee Mattikalli, Yun‐Xing Wang, Lixin Fan, Xinghai Li, Smita K. Nair, Ashutosh Chilkoti   +16 more
wiley   +1 more source

Using the CARD system for university-based pop-up vaccination clinics: A two-stage hybrid effectiveness-implementation study. [PDF]

Hum Vaccin Immunother
Gudzak V, Logeman C, Crown N, Ilersich ANT, Folinas M, McMurtry CM, Bucci LM, Shea C, Shah V, Boon H, Katz J, Dolovich L, Taddio A.   +12 more
europepmc   +1 more source

BCG‐Derived Outer Membrane Vesicles Induce TLR2‐Dependent Trained Immunity to Protect Against Polymicrobial Sepsis

Advanced Science, EarlyView.
B‐OMVs, nanoscale vesicles derived from BCG, are identified as effective and safe inducers of trained immunity that protect against sepsis. Through TLR2‐mediated metabolic and epigenetic reprogramming of hematopoietic stem cells, B‐OMVs enhance inflammatory response and phagocytic activity.
Yuan Gong, Wenyan Hao, Lingqi Xu, Yingyi Yang, Zhenzhen Dong, Peng Pan, Zhenjiang Bai, Jie Huang, Kaidi Yang, Zhu Jin, Rui Kang, Qiang Shan, Jiang huai Wang, Zijian Zhou, Daolin Tang, Jian Wang, Huiting Zhou   +16 more
wiley   +1 more source

Beliefs related to COVID-19 vaccine receipt in the Chicago area. [PDF]

Discov Public Health
Lomahan S, Silva A, Bishop-Royse J, Thomas P, Martin MA.   +4 more
europepmc   +1 more source